Related Experiment Videos
Purification of GSK-3 by affinity chromatography on immobilized axin
A Primot1, B Baratte, M Gompel
1Station Biologique, CNRS, BP 74, 29682 Roscoff cedex, Bretagne, France.
Abstract:
Glycogen synthase kinase 3 (GSK-3), an element of the Wnt signalling pathway, plays a key role in numerous cellular processes including cell proliferation, embryonic development, and neuronal functions. It is directly involved in diseases such as cancer (by controlling apoptosis and the levels of beta-catenin and cyclin D1), Alzheimer's disease (tau hyperphosphorylation), and diabetes (as a downstream element of insulin action, GSK-3 regulates glycogen and lipid synthesis). We describe here a rapid and efficient method for the purification of GSK-3 by affinity chromatography on an immobilized fragment of axin. Axin is a docking protein which interacts with GSK-3ss, beta-catenin, phosphatase 2A, and APC. A polyhistidine-tagged axin peptide (residues 419-672) was produced in Escherichia coli and either immobilized on Ni-NTA agarose beads or purified and immobilized on CNBr-activated Sepharose 4B. These "Axin-His6" matrices were found to selectively bind recombinant rat GSK-3 beta and native GSK-3 from yeast, sea urchin embryos, and porcine brain. The affinity-purified enzymes displayed high kinase activity. This single step purification method provides a convenient tool to follow the status of GSK-3 (protein level, phosphorylation state, kinase activity) under various physiological settings. It also provides a simple and efficient way to purify large amounts of active recombinant or native GSK-3 for screening purposes.
Insights
Researchers developed a fast affinity chromatography method using an axin peptide to purify Glycogen synthase kinase 3 (GSK-3). This technique efficiently isolates active GSK-3 for studying cellular processes and diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- Glycogen synthase kinase 3 (GSK-3) is crucial in cellular processes like proliferation, development, and neuronal function.
- Dysregulation of GSK-3 is implicated in diseases including cancer, Alzheimer's, and diabetes.
- Existing methods for GSK-3 purification can be inefficient.
Purpose of the Study:
- To develop a rapid and efficient method for purifying Glycogen synthase kinase 3 (GSK-3).
- To create a tool for studying GSK-3's status (protein level, phosphorylation, activity) in various physiological conditions.
- To enable large-scale purification of active GSK-3 for screening purposes.
Main Methods:
- Affinity chromatography using an immobilized polyhistidine-tagged axin peptide (residues 419-672).
- Production of the axin peptide in Escherichia coli.
- Immobilization of the peptide on Ni-NTA agarose beads or CNBr-activated Sepharose 4B.
Main Results:
- The "Axin-His6" matrices selectively bound both recombinant rat GSK-3 beta and native GSK-3 from diverse sources (yeast, sea urchin, porcine brain).
- Affinity-purified GSK-3 enzymes exhibited high kinase activity.
- The single-step purification method proved effective and convenient.
Conclusions:
- A novel, efficient single-step affinity purification method for GSK-3 was established using an axin fragment.
- This method facilitates the study of GSK-3 in various biological contexts and disease states.
- The technique provides a valuable tool for obtaining active GSK-3 for biochemical assays and screening.